Improving the science of abuse assessment before a drug is marketed is a unified goal for the FDA and pharmaceutical industry. It is the hope that public health will be protected through placing appropriate controls, such as accurate labeling information and marketing practices, to reduce the likelihood that a drug will be abused after FDA approval.
Tips for Managing Stress During COVID-19
With so much uncertainty about the future of our health, economy, and the state of the world, our mental health is put at risk. According to the…
Achieving Challenging Recruitment Goals and Timelines in a Pediatric Type 2 Diabetes Study
Recruiting pediatric patients for type 2 diabetes mellitus (T2DM) studies is extremely challenging. Patients are difficult to identify and often face…
Clinical Trials in Children with Impaired Mental Capacity
Download this resource to learn how to conduct studies with patients who lack legal competence and the 4 ethical pillars of medical research.